Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

Cytochrome P-450-Dependent Bioactivation of 1,1-Dichloroethylene to a Reactive Epoxide in Human Lung and Liver Microsomes

Taylor F. Dowsley, Ken Reid, Dimitri Petsikas, Judith B. Ulreich, Robyn L. Fisher and Poh-Gek Forkert
Journal of Pharmacology and Experimental Therapeutics May 1999, 289 (2) 641-648;
Taylor F. Dowsley
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken Reid
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dimitri Petsikas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Judith B. Ulreich
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robyn L. Fisher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Poh-Gek Forkert
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

We investigated the cytochrome P-450-dependent metabolism of 1,1-dichloroethylene (DCE) by human lung and liver microsomes and compared the results from analogous experiments in mice. Metabolites were identified by HPLC analysis of their glutathione conjugates and/or hydrolyzed products and were detected by using [14C]DCE. The role of human CYP2E1 in the metabolic reactions was examined by comparing p-nitrophenol hydroxylase activities with levels of metabolites formed and by using the CYP2E1-selective inhibitor diallyl sulfone. The major products formed in microsomal incubations containing NADPH were the DCE-epoxide-derived glutathione conjugates 2-(S-glutathionyl)acetyl glutathione and 2-S-glutathionyl acetate. Lower levels of the acetal of 2,2-dichloroacetaldehyde were also detected. In lung samples from eight patients, the amounts of epoxide-derived conjugates formed ranged from 15.6 ± 4.23 to 34.9 ± 12.75 pmol/mg protein/min. The levels in murine lung were higher at 40.0 ± 3.8 pmol/mg protein/min. In liver samples from five patients, conjugate levels ranged from 46.5 ± 8.3 to 240.0 ± 10.5 pmol/mg protein/min, whereas levels in murine liver were 83.0 ± 6.2 pmol/mg protein/min. Conjugate levels formed in human liver correlated with the relative levels of p-nitrophenol hydroxylase activity present, but this relationship was equivocal in human lung. Diallyl sulfone inhibited the formation of the glutathione conjugates (20–65%) in liver samples from all four patients, whereas only one of five human lung samples exhibited this inhibition (27%). These results demonstrated that the DCE-epoxide is a major metabolite formed by human microsomes and is mediated by CYP2E1 in liver and in some individuals in lung.

Footnotes

  • Send reprint requests to: Dr. Poh-Gek Forkert, Department of Anatomy and Cell Biology, Kingston, Ontario, Canada K7L 3N6. E-mailforkertp{at}post.queensu.ca

  • ↵1 This research was supported by Grant MT-11706 from the Medical Research Council of Canada (to P.G.F.), Grant RO1-CA73220-01 from the U.S. National Cancer Institute (to P.G.F.), the Arizona Disease Control Research Commission (to J.B.U.), and National Institute of Environmental Health Sciences Center Grant P30-ES-06694 (to J.B.U).

  • Abbreviations:
    [A]
    S-(2,2-dichloro-1-hydroxy)ethyl glutathione
    [B]
    2-(S-glutathionyl) acetyl glutathione
    [C]
    2-S-glutathionyl acetate
    [D]
    S-(2-chloroacetyl)-glutathione
    DASO2
    diallyl sulfone
    DCE
    1,1-dichloroethylene
    GSH
    glutathione
    PNP
    p-nitrophenol
    • Received September 23, 1998.
    • Accepted December 3, 1998.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 289 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 289, Issue 2
1 May 1999
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Cytochrome P-450-Dependent Bioactivation of 1,1-Dichloroethylene to a Reactive Epoxide in Human Lung and Liver Microsomes
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Cytochrome P-450-Dependent Bioactivation of 1,1-Dichloroethylene to a Reactive Epoxide in Human Lung and Liver Microsomes

Taylor F. Dowsley, Ken Reid, Dimitri Petsikas, Judith B. Ulreich, Robyn L. Fisher and Poh-Gek Forkert
Journal of Pharmacology and Experimental Therapeutics May 1, 1999, 289 (2) 641-648;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Cytochrome P-450-Dependent Bioactivation of 1,1-Dichloroethylene to a Reactive Epoxide in Human Lung and Liver Microsomes

Taylor F. Dowsley, Ken Reid, Dimitri Petsikas, Judith B. Ulreich, Robyn L. Fisher and Poh-Gek Forkert
Journal of Pharmacology and Experimental Therapeutics May 1, 1999, 289 (2) 641-648;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Interaction of Diclofenac and Quinidine in Monkeys: Stimulation of Diclofenac Metabolism
  • Is Hydroxylamine-Induced Cytotoxicity a Valid Marker for Hypersensitivity Reactions to Sulfamethoxazole in Human Immunodeficiency Virus-Infected Individuals?
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics